Keyword: Relay Therapeutics
Relay Therapeutics reeled in a $400 million round to boost its platform technology and discovery efforts, build its pipeline and get into the clinic.
Xenotransplantation firm eGenesis hires new R&D head; Relay adds execs to chemistry, R&D; and Navidea brings on new CMO focused on imaging.
Relay Therapeutics brought on Verastem’s Mahesh Padval and Eli Lilly’s Mary Mader as it begins to transition to a development-stage biotech.
Celgene COO Scott Smith resigns, ex-Kite leaders Belldegrun and Chang form new CAR-T shop, GSK Dermatology exec jumps to Dermavant.
Relay Therapeutics has bumped up its cash with a strong second funding round as it eyes clinical work on its next-gen cancer drug development.
Pfizer creates COO role, Bayer replaces consumer health chief, Turnstone poaches Bristol-Myers executive as new R&D head and more.